Skip to content

Drug interactions

Metformin-sitagliptin + Octreotide

Severity: Moderate

Metformin-sitagliptin and Octreotide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Octreotide suppresses insulin, glucagon and growth hormone, so it can cause either hypoglycemia or hyperglycemia. This can alter the glucose control achieved with metformin and sitagliptin.

What this interaction means in plain words

Metformin-sitagliptin and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Metformin-sitagliptin belongs to Endocrine; Octreotide belongs to Endocrine.

Evidence level: Moderate

Why it happens

Somatostatin analogue inhibition of insulin and counter-regulatory hormone secretion changes glucose homeostasis.

What to do

Monitor blood glucose when starting, stopping or changing the octreotide dose and adjust antidiabetic therapy accordingly.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Metformin-sitagliptin and Octreotide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Metformin-sitagliptin with Octreotide?

MediHelp rates the interaction as moderate. Metformin-sitagliptin and Octreotide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Octreotide suppresses insulin, glucagon and growth hormone, so it can cause either hypoglycemia or hyperglycemia. This can alter the glucose control achieved with metformin and sitagliptin.

How serious is the interaction between Metformin-sitagliptin and Octreotide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when starting, stopping or changing the octreotide dose and adjust antidiabetic therapy accordingly.

What other medicines interact with Metformin-sitagliptin?

MediHelp also lists interactions of Metformin-sitagliptin with, for example, Clozapine, Contrast media, Diatrizoate meglumine / diatrizoate. The full list is on the Metformin-sitagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in